CO4750668A1 - Ascomicinas - Google Patents

Ascomicinas

Info

Publication number
CO4750668A1
CO4750668A1 CO96016454A CO96016454A CO4750668A1 CO 4750668 A1 CO4750668 A1 CO 4750668A1 CO 96016454 A CO96016454 A CO 96016454A CO 96016454 A CO96016454 A CO 96016454A CO 4750668 A1 CO4750668 A1 CO 4750668A1
Authority
CO
Colombia
Prior art keywords
alkoxy
oxycarbonyl
phenylene
oxo
hydroxy
Prior art date
Application number
CO96016454A
Other languages
English (en)
Inventor
Rene Hersperger
Reto Naef
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9507128.8A external-priority patent/GB9507128D0/en
Priority claimed from GBGB9526049.3A external-priority patent/GB9526049D0/en
Priority claimed from GBGB9526050.1A external-priority patent/GB9526050D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of CO4750668A1 publication Critical patent/CO4750668A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Un compuesto de la Fórmula I:caracterizado porque Y es fenileno o metileno;Z se selecciona de carboxi y oxicarbonilo fisiológicamente hidrolizable, o cuando Y es fenileno, también se selecciona de un grupo alquilo, alcoxi, alquilamino o dialquilamino que porta de uno a cuatro porciones carboxi o porciones oxicarbonilo fisiológicamente hidrolizables; Q es O ó S; R1 es H, alquilo o arilo; R2 es hidrógeno o hidroxi; R3 es metilo, etilo, propilo o alilo; R4 es hidroxi o alcoxi; R5 es oxo o (H, OH); R6 e oxo, (H, OH) o (H, alcoxi); n es 1 ó 2; y el enlace representado por líneas sólidas paralelas y líneas punteadas es ya sea un enlace sencillo o un enlace doble; en forma libre o en forma de sal fisiológicamente aceptable.
CO96016454A 1995-04-06 1996-04-03 Ascomicinas CO4750668A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9507128.8A GB9507128D0 (en) 1995-04-06 1995-04-06 Organic compounds
GBGB9526049.3A GB9526049D0 (en) 1995-12-20 1995-12-20 Organic compounds
GBGB9526050.1A GB9526050D0 (en) 1995-12-20 1995-12-20 Organic compounds

Publications (1)

Publication Number Publication Date
CO4750668A1 true CO4750668A1 (es) 1999-03-31

Family

ID=27267660

Family Applications (1)

Application Number Title Priority Date Filing Date
CO96016454A CO4750668A1 (es) 1995-04-06 1996-04-03 Ascomicinas

Country Status (21)

Country Link
US (1) US5925649A (es)
EP (1) EP0819130A1 (es)
JP (1) JP2000505044A (es)
KR (1) KR19980703583A (es)
CN (1) CN1088068C (es)
AR (1) AR004480A1 (es)
AU (1) AU703523B2 (es)
BR (1) BR9604808A (es)
CA (1) CA2216562A1 (es)
CO (1) CO4750668A1 (es)
CZ (1) CZ312397A3 (es)
FI (1) FI973529A (es)
HU (1) HUP9801993A3 (es)
IL (1) IL117815A (es)
MX (1) MX9707636A (es)
NO (1) NO309273B1 (es)
NZ (1) NZ307170A (es)
PL (1) PL322553A1 (es)
SK (1) SK133997A3 (es)
TR (1) TR199700999T1 (es)
WO (1) WO1996031514A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2367294T3 (es) 1998-03-26 2011-11-02 Astellas Pharma Inc. Preparación de liberación sostenida de un compuesto macrólido como tacrolimus.
GB9826656D0 (en) * 1998-12-03 1999-01-27 Novartis Ag Organic compounds
US6121257A (en) * 1999-03-31 2000-09-19 Abbott Laboratories Sulfamate containing macrocyclic immunomodulators
US7063857B1 (en) 1999-04-30 2006-06-20 Sucampo Ag Use of macrolide compounds for the treatment of dry eye
CZ20013769A3 (cs) * 1999-04-30 2002-03-13 Sucampo Ag Činidlo pro léčbu suchého oka
EP1210121A2 (en) 1999-08-24 2002-06-05 Cellgate Inc. Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties
AR033151A1 (es) * 2001-04-12 2003-12-03 Sucampo Pharmaceuticals Inc Agente para el tratamiento oftalmico topico de las enfermedades inflamatorias oculares
WO2002089796A2 (en) * 2001-05-09 2002-11-14 Novartis Ag Methods for selective immunomodulation using pimecrolimus
KR20050086648A (ko) * 2002-11-15 2005-08-30 노파르티스 아게 약물 전달 시스템
EP1594484A2 (en) * 2003-02-17 2005-11-16 Cipla Ltd. Pharmaceutical patch
TWI324604B (en) * 2003-06-18 2010-05-11 Novartis Ag New use of staurosporine derivatives
US7780973B2 (en) * 2003-12-15 2010-08-24 Ethicon Endo-Surgery, Inc. Method and device for minimally invasive implantation of biomaterial
US20050142161A1 (en) * 2003-12-30 2005-06-30 Freeman Lynetta J. Collagen matrix for soft tissue augmentation
EP1699456A1 (en) * 2003-12-30 2006-09-13 Astellas Pharma Inc. Use of macrolides for treating or preventing airflow obstruction
EP1848541A4 (en) * 2005-02-07 2013-01-16 Pharmalight Inc METHOD AND DEVICE FOR OPHTHALMIC DELIVERY OF PHARMACEUTICALLY ACTIVE INGREDIENTS
ES2898849T3 (es) 2014-10-28 2022-03-09 Koushi Yamaguchi Medicamento para mejorar el síndrome de hipertensión inducida por el embarazo
CA3108863A1 (en) 2018-08-10 2020-02-13 Koushi Yamaguchi Therapeutic agent for humoral immunity-related diseases in materno-fetal relationship
CN113226331A (zh) 2018-12-18 2021-08-06 山口晃史 用于改善不孕不育症或妊娠状态的药物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3244592A (en) * 1962-06-09 1966-04-05 Arai Tadashi Ascomycin and process for its production
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
JPS6317884A (ja) * 1986-05-30 1988-01-25 Fujisawa Pharmaceut Co Ltd トリシクロ化合物
JPH01125394A (ja) * 1987-11-10 1989-05-17 Mect Corp シアロシルグリセロリピッド類及びその製造方法
DE3853477T2 (de) * 1987-12-09 1995-11-09 Fisons Plc Makrozyklische verbindungen.
JPH05504944A (ja) * 1989-08-18 1993-07-29 藤沢薬品工業株式会社 巨大環式化合物
KR0159766B1 (ko) * 1989-10-16 1998-12-01 후지사와 토모키치로 양모제 조성물
NZ235991A (en) * 1989-11-09 1993-05-26 Sandoz Ltd Macrolide compounds and pharmaceutical compositions thereof
WO1991013899A1 (en) * 1990-03-12 1991-09-19 Fujisawa Pharmaceutical Co., Ltd. Tricyclo compounds
JPH05507915A (ja) * 1990-06-11 1993-11-11 藤沢薬品工業株式会社 特発性血小板減少性紫斑病およびバセドウ病治療薬製造のためのｆｋ５０６等のマクロライド化合物の用途
MY110418A (en) * 1990-07-02 1998-05-30 Novartis Ag Heteroatoms-containing tricyclic compounds.
DE69125230T2 (de) * 1990-09-04 1997-07-10 Fujisawa Pharmaceutical Co Tricyclische Verbindungen enthaltende Salben
IE65341B1 (en) * 1990-11-08 1995-10-18 Fujisawa Pharmaceutical Co Suspensions containing tricyclic compounds
US5208241A (en) * 1991-09-09 1993-05-04 Merck & Co., Inc. N-heteroaryl, n-alkylheteroaryl, n-alkenylheteroaryl and n-alkynylheteroarylmacrolides having immunosuppressive activity
US5252732A (en) * 1991-09-09 1993-10-12 Merck & Co., Inc. D-heteroaryl, O-alkylheteroaryl, O-alkenylheteroaryl and O-alkynylheteroarylmacrolides having immunosuppressive activity
US5247076A (en) * 1991-09-09 1993-09-21 Merck & Co., Inc. Imidazolidyl macrolides having immunosuppressive activity
US5457194A (en) * 1993-03-17 1995-10-10 Abbott Laboratories Substituted aliphatic amine-containing macrocyclic immunomodulators
AU714254B2 (en) * 1994-10-26 1999-12-23 Novartis Ag Pharmaceutical compositions

Also Published As

Publication number Publication date
KR19980703583A (ko) 1998-11-05
BR9604808A (pt) 1998-06-09
AU5645396A (en) 1996-10-23
CZ312397A3 (cs) 1998-01-14
AR004480A1 (es) 1998-12-16
NZ307170A (en) 1999-03-29
HUP9801993A2 (hu) 1998-12-28
HUP9801993A3 (en) 2000-04-28
CN1180359A (zh) 1998-04-29
SK133997A3 (en) 1998-05-06
FI973529A (fi) 1997-11-25
WO1996031514A1 (en) 1996-10-10
MX9707636A (es) 1998-06-30
CN1088068C (zh) 2002-07-24
PL322553A1 (en) 1998-02-02
JP2000505044A (ja) 2000-04-25
IL117815A0 (en) 1996-08-04
NO309273B1 (no) 2001-01-08
IL117815A (en) 2000-07-16
AU703523B2 (en) 1999-03-25
CA2216562A1 (en) 1996-10-10
TR199700999T1 (xx) 1998-01-21
NO974536D0 (no) 1997-10-01
EP0819130A1 (en) 1998-01-21
NO974536L (no) 1997-10-01
FI973529A0 (fi) 1997-08-27
US5925649A (en) 1999-07-20

Similar Documents

Publication Publication Date Title
CO4750668A1 (es) Ascomicinas
DE69303032D1 (de) Als süsstoffe brauchbare verbindungen und hir herstellungsverfahren
TW334420B (en) Piperidine derivatives and intermediates
AU5261598A (en) A1 adenosine receptor antagonists
EP0870765A4 (es)
FI864527A (fi) Tricyklofoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandning.
PE2599A1 (es) Compuesto heterociclo inhibidor de metaloproteasa
FI970417A0 (fi) Aryylitioyhdisteet bakteerien ja virusten vastaisina aineina
ES2012646A6 (es) Un procedimiento para la preparacion de derivados de piridazinona.
HK1019878A1 (en) Total synthesis of antitumor acylfulvenes.
ES2165274A1 (es) Nuevos derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
TR199701287T1 (xx) Azasikloalkan t�revleri, haz�rlan��lar� ve terapideki uygulamalar�.
WO2002000638A3 (en) Substituted phthalides as anti-convulsive drugs
EP0947504A4 (es)
ZA908928B (en) Use of 6-or 7-hydroxyindole derivatives as couplers and dyeing compositions and methods using these
ATE43589T1 (de) Neue prostacyclinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ZA9811380B (es)
NO994931D0 (no) Chelateringsmidler
ATE197297T1 (de) 3-oxo-1,4-benzothiazin-derivate
KR920700030A (ko) 진양성 조성물
ZA962037B (en) 17-difluoromethylene-estratriene
EP0987247A4 (en) ITACONATE DERIVATIVES AND THEIR USE AS COMPONENTS IN A POLYMER
TW276257B (es)
TW353662B (en) Cephalosporin salts and process for the preparation thereof
ATE148462T1 (de) Isoxazole derivate als lichtschutzmittel